Literature DB >> 8347489

Interaction of multidrug-resistant Chinese hamster ovary cells with amphiphiles.

D W Loe1, F J Sharom.   

Abstract

The interaction of membrane-active amphiphiles with a series of MDR Chinese hamster ovary (CHO) cell lines was investigated. Cross-resistance to cationic amphiphiles was observed, which was effectively sensitised by verapamil. MDR cells showed collateral sensitivity to polyoxyethylene amphiphiles (Triton X-100/Nonidet P-40), which reached a maximum at 9-10 ethylene oxide units. Resistant lines were also highly collaterally sensitive (17-fold) to dibutylphthalate. mdrl transfectants showed cross-resistance to cationic amphiphiles, but no collateral sensitivity to nonionic species. Triton X-100/Nonidet P-40 inhibited 3H-azidopine photoaffinity labelling at low concentrations, perhaps reflecting a specific interaction with P-glycoprotein. Further investigation of the molecular basis of collateral sensitivity revealed that association of 3H-Triton X-100 with MDR cells reached steady state levels rapidly, and occurred by a non-mediated mechanism. The equilibrium level of X-100 uptake was inversely related to drug resistance. Collateral sensitivity is thus not a result of decreased Triton X-100 association with the cell. The fluorescent probe merocyanine 540 was used to examine the MDR plasma membrane microenvironment for physicochemical changes. Increasing levels of drug resistance correlated with a progressive shift in the mean cell fluorescence to lower levels, which suggests that the packing density in the outer leaflet of MDR cells is increased relative to that of the drug-sensitive parent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8347489      PMCID: PMC1968548          DOI: 10.1038/bjc.1993.338

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

Review 1.  Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy.

Authors:  E Georges; F J Sharom; V Ling
Journal:  Adv Pharmacol       Date:  1990

Review 2.  Genetic and biochemical characterization of multidrug resistance.

Authors:  J R Riordan; V Ling
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

Review 3.  Multidrug-resistance phenotype in Chinese hamster ovary cells.

Authors:  V Ling; N Kartner; T Sudo; L Siminovitch; J R Riordan
Journal:  Cancer Treat Rep       Date:  1983-10

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Isolation and expression of a complementary DNA that confers multidrug resistance.

Authors:  P Gros; Y B Ben Neriah; J M Croop; D E Housman
Journal:  Nature       Date:  1986 Oct 23-29       Impact factor: 49.962

6.  Circumvention of multidrug-resistance in P388 cells is associated with a rise in the cellular content of phosphatidylcholine.

Authors:  A Ramu; N Ramu; L M Rosario
Journal:  Biochem Pharmacol       Date:  1991-05-15       Impact factor: 5.858

7.  Merocyanine 540, a fluorescent probe sensitive to lipid packing.

Authors:  P Williamson; K Mattocks; R A Schlegel
Journal:  Biochim Biophys Acta       Date:  1983-07-27

8.  The effects of lipids and detergents on ATPase-active P-glycoprotein.

Authors:  C A Doige; X Yu; F J Sharom
Journal:  Biochim Biophys Acta       Date:  1993-02-23

9.  Co-amplification of double minute chromosomes, multiple drug resistance, and cell surface P-glycoprotein in DNA-mediated transformants of mouse cells.

Authors:  S M Robertson; V Ling; C P Stanners
Journal:  Mol Cell Biol       Date:  1984-03       Impact factor: 4.272

10.  Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists.

Authors:  W D Klohs; R W Steinkampf; M J Havlick; R C Jackson
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

View more
  7 in total

Review 1.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

2.  Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation.

Authors:  F J Sharom; P Lu; R Liu; X Yu
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

Review 3.  Characterization and functional reconstitution of the multidrug transporter.

Authors:  F J Sharom
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

4.  Nonylphenolethoxylates as malarial chloroquine resistance reversal agents.

Authors:  I Crandall; J Charuk; K C Kain
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

5.  Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport.

Authors:  F J Sharom; X Yu; G DiDiodato; J W Chu
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

6.  Modulation of Multidrug Resistance in Cancer by Immunosuppresive Agents. Preclinical Studies.

Authors:  Adorján Aszalos
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

Review 7.  Complex Interplay between the P-Glycoprotein Multidrug Efflux Pump and the Membrane: Its Role in Modulating Protein Function.

Authors:  Frances Jane Sharom
Journal:  Front Oncol       Date:  2014-03-03       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.